Oct. 17, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced that it will report financial results for the third quarter 2022 after market close on Monday, November 7, 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET.
Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register online to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
Source: Quantum-Si Incorporated
View source version on businesswire.com: https://www.businesswire.com/news/home/20221017005824/en/
Contacts
Investors
Juan Avendano
ir@quantum-si.com
Media
Shawna Marino
media@quantum-si.com
